It was established in 2007 by investment bankers Burrill & Co., of San Francisco, and Kuwait Life Sciences Co., the life sciences arm of Kuwait's National Technology Enterprises Co. (NTEC), in order to in-license and market biologic and small-molecule drugs in the Middle East, Africa, Turkey and Caspian Sea region
By Cormac Sheridan | BioWorld Today | Tuesday, May 21, 2013
life science companies Avalon will provide up to $30M, while GSK will contribute seed funding, research and development support and success-based preclinical and clinical milestone payments up to a total of $465M for the 10 companies 4/24/13 Merck & Co
It was established in 2007 by investment bankers Burrill & Co., of San Francisco, and Kuwait Life Sciences Co., the life sciences arm of Kuwait's National Technology Enterprises Co. (NTEC), in order to in-license and market biologic and small-molecule drugs in the Middle East, Africa, Turkey and Caspian Sea region